Tables of Rules

INTEGRASE INHIBITOR
Nucleoside and Nucleotide reverse transcriptase inhibitors Protease inhibitors

Non-Nucleoside reverse transcriptase inhibitors Fusion inhibitors

HIV - 2 Integrase inhibitors

  Mutations associated with resistance Mutations associated with possible resistance
RAL
 Q148H/G/K/R/E [1, 2]
N155H [1, 2]
E157Q [2]
E92Q [1, 2]
G140A/S [7]
Y143C/H/R [1, 3, 4, 5]
3 mutations among : V72I, L74M, T97A, V151I, G163R, S230R [8]
EVG T66I/A/K [6]
E92Q [6]
E138K
G140C/S
S147G
Q148H/R/K [6]
N155H [6]

RAL: raltegravir, EVG: elvitegravir.

References